ClinicalTrials.Veeva

Menu

Testing the Persuasiveness of Pro-inoculation Arguments

University of Pennsylvania logo

University of Pennsylvania

Status

Completed

Conditions

Human Papillomavirus Vaccination
Vaccine Refusal
Vaccination Hesitancy

Treatments

Behavioral: Simple forewarning message
Behavioral: Argument inoculation messages

Study type

Interventional

Funder types

Other

Identifiers

NCT05804825
dfjgehea

Details and patient eligibility

About

The investigators will recruit a national sample of parents of 7-10-year-olds to complete an argument strength ranking for either a simple forwarding message or between 3 and 6 randomly selected arguments from an overall set of 50 to 100 messages identified from various online sources. Parents will rate each message they see on measures of perceived argument strength/PME. Parents will also answer sociodemographic questions and then rank the believability of a set of anti-vaccine messages identified in a different study. Study findings will contribute valuable information to understanding the effectiveness of different inoculation messages.

Enrollment

523 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Male or female parent or legal guardian of an adolescent ages 7-10
  2. Age eligible child has not yet received any doses of the HPV vaccine
  3. Resides in the United States
  4. English speaking
  5. Completed informed consent

Exclusion criteria

  1. Unable to read English at a 6th grade literacy level
  2. Age < 18
  3. Does not have a child within the age range of 7-10
  4. Age-eligible child has received 1 or more doses of the HPV vaccine
  5. Does not have a social media account on one or more of the following platforms OR does not read online news stories: Twitter, Instagram, YouTube, Facebook (feasibility testing only - survey participation will not have this exclusion criteria)
  6. Unwilling or unable to provide informed consent to study participation

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

523 participants in 2 patient groups

Simple forewarning message
Active Comparator group
Description:
Participants will receive a simple short forewarning message to read and rate.
Treatment:
Behavioral: Simple forewarning message
Argument inoculation messages
Experimental group
Description:
Participants will view a random sample of 3 text-only short messages (from a corpus of 100 arguments) to read and rate.
Treatment:
Behavioral: Argument inoculation messages

Trial contacts and locations

1

Loading...

Central trial contact

Jennifer Morgan, PhD; Melanie L Kornides, ScD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems